There are also tumors which are considered medullary carcinomas with thyroglobulin immunoreactivity [19], since they do not fulfill the WHO criteria for “mixed medullary-follicular carcinomas,” it is very difficult to set accurate results. This evidence concerns the gene TG and thyroid gland follicular carcinoma.